Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Palgrave Handbook of Disability Sport in Europe: Policies, Structures, and Participation.

Adapted physical activity quarterly : APAQ·2024
Same author

Antiphospholipid Syndrome: Thrombotic and Vascular Complications.

Cardiology in review·2023
Same author

Cardiovascular Manifestations of Systemic Sclerosis: An Overview of Pathophysiology, Screening Modalities, and Treatment Options.

Cardiology in review·2021
Same author

Sarcoid Heart Disease: Review of Current Knowledge.

Cardiology in review·2021
Same author

Cardiac Manifestations of Systemic Lupus Erythematous: An Overview of the Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology and Treatment Options.

Cardiology in review·2020
Same author

The Magnetic Resonance Imaging Appearance of Endoscopic Endonasal Skull Base Defect Reconstruction Using Free Mucosal Graft.

World neurosurgery·2019
Same journal

Heparin-induced thrombocytopenia and thrombosis.

Comprehensive therapy·2011
Same journal

Antiplatelet therapy in cardiovascular disease.

Comprehensive therapy·2011
Same journal

Genetics of cardiovascular disease.

Comprehensive therapy·2011
Same journal

Septic renal vein thrombosis complicated by septic pulmonary embolism.

Comprehensive therapy·2011
Same journal

Problems with computerized health records.

Comprehensive therapy·2011
Same journal

Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.

Comprehensive therapy·2010
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

Gout and hyperuricemia.

Chandra S Chilappa1, Wilbert S Aronow, Deborah Shapiro

  • 1Department of Medicine, Division of Rheumatology New York Medical College, Valhalla, NY 10595, USA.

Comprehensive Therapy
|January 15, 2011
PubMed
Summary
This summary is machine-generated.

Hyperuricemia, or high uric acid in blood, can lead to gout. This metabolic disease involves crystal deposition and intense joint inflammation, ranging from mild to severe chronic conditions.

Related Experiment Videos

Last Updated: Jun 5, 2026

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

Area of Science:

  • Rheumatology
  • Metabolic Medicine
  • Biochemistry

Background:

  • Hyperuricemia signifies elevated uric acid levels in the blood.
  • Gout is a prevalent systemic metabolic disorder.
  • Characterized by monosodium urate monohydrate crystal deposition, leading to acute joint inflammation.

Purpose of the Study:

  • To define hyperuricemia and its relationship to gout.
  • To describe the clinical manifestations of gout.
  • To outline the spectrum of gout disease progression.

Main Methods:

  • Literature review of hyperuricemia and gout.
  • Analysis of clinical case studies.
  • Pathophysiological examination of crystal-induced inflammation.

Main Results:

  • Hyperuricemia is a key precursor to gout development.
  • Gout presents with acute, intense joint inflammation.
  • The disease spectrum includes asymptomatic hyperuricemia, acute gouty arthritis, chronic tophaceous gout, and chronic gouty arthropathy.

Conclusions:

  • Hyperuricemia is the underlying metabolic abnormality in gout.
  • Gout is a progressive inflammatory arthropathy.
  • Understanding the clinical spectrum is crucial for patient management.